Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05062980
Title Reqorsa (Quaratusugene Ozeplasmid) in Combination With Pembrolizumab in Previously Treated Non-Small Lung Cancer (Acclaim-2)
Acronym Acclaim-2
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Genprex, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Moffitt Cancer Center - Magnolia Campus RECRUITING Tampa Florida 33612 United States Details
Ochsner Clinic Foundation RECRUITING New Orleans Louisiana 70121 United States Details
Washington University School of Medicine - Siteman Cancer Center RECRUITING Saint Louis Missouri 63110 United States Details
Mary Crowley Cancer Research RECRUITING Dallas Texas 75230 United States Details
Millennium Oncology RECRUITING Houston Texas 77090 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field